FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3023862215> ?p ?o ?g. }

• W3023862215 endingPage "e19989" @default.
• W3023862215 startingPage "e19989" @default.
• W3023862215 abstract "This study aimed to establish an optimal protocol for 99mTc-sestamibi parathyroid imaging for lesion localization in patients with hyperparathyroidism (HPT). We retrospectively enrolled 35 consecutive patients who underwent dual-phase (at 10 minutes and 120 minutes) 99mTc-sestamibi parathyroid scintigraphy with single-photon emission computed tomography (SPECT)/computed tomography (CT). Twenty seven patients had primary HPT, and 8 had secondary or tertiary HPT. Three nuclear medicine physicians independently analyzed the parathyroid images for lesion localization at 9 predefined parathyroid locations using the following 4 different image sets blinded to the clinical information: 1. dual-phase SPECT, 2. early SPECT/CT, 3. delayed SPECT/CT, 4. dual-phase SPECT/CT. All SPECT or SPECT/CT image sets were analyzed with dual-phase planar images. The image results were compared with the histopathological results after surgery. Dual-phase SPECT/CT showed the highest positive rate of 85.7% in the patient-based analysis and 13.7% in the location-based analysis. Of 35 patients, surgical pathological results were available in 21 (16 adenomas in 16 primary HPTs and 16 hyperplasias in 5 secondary or tertiary HPTs). Dual-phase SPECT/CT showed the sensitivity values of 100% and 84.4% in the patient-based and location-based analysis, respectively, which were the highest sensitivity values among all image sets. In the primary HPT subgroup, dual-phase SPECT/CT showed the highest sensitivity value of 93.8% in the location-based analyses, whereas dual-phase SPECT, early SPECT/CT, and delayed SPECT/CT showed the sensitivity values of 62.5%, 81.3%, and 81.3%, respectively. In the secondary or tertiary HPT subgroup, dual-phase SPECT/CT also showed the highest sensitivity value of 75.0%, whereas early SPECT/CT, delayed SPECT/CT, and dual-phase SPECT showed the sensitivity values of 43.8%, 56.3%, and 68.8%, respectively. Compared with dual-phase SPECT or single-phase SPECT/CT, the dual-phase SPECT/CT imaging protocol for 99mTc-sestamibi scintigraphy showed the highest positive rate and sensitivity, and was optimal for parathyroid lesion localization." @default.
• W3023862215 created "2020-05-13" @default.
• W3023862215 creator A5027438574 @default.
• W3023862215 creator A5036897219 @default.
• W3023862215 creator A5066805252 @default.
• W3023862215 creator A5070127299 @default.
• W3023862215 creator A5070396701 @default.
• W3023862215 creator A5091021089 @default.
• W3023862215 date "2020-05-01" @default.
• W3023862215 modified "2023-09-27" @default.
• W3023862215 title "Is dual-phase SPECT/CT with 99mTc-sestamibi better than single-phase SPECT/CT for lesion localization in patients with hyperparathyroidism?" @default.
• W3023862215 cites W1506013501 @default.
• W3023862215 cites W1747969671 @default.
• W3023862215 cites W1859039620 @default.
• W3023862215 cites W1929750271 @default.
• W3023862215 cites W1975398760 @default.
• W3023862215 cites W1992247096 @default.
• W3023862215 cites W2005280280 @default.
• W3023862215 cites W2010333383 @default.
• W3023862215 cites W2014297682 @default.
• W3023862215 cites W2022639824 @default.
• W3023862215 cites W2046754876 @default.
• W3023862215 cites W2057504569 @default.
• W3023862215 cites W2062447783 @default.
• W3023862215 cites W2078950389 @default.
• W3023862215 cites W2079103441 @default.
• W3023862215 cites W2098410854 @default.
• W3023862215 cites W2137266781 @default.
• W3023862215 cites W2152366139 @default.
• W3023862215 cites W2158878495 @default.
• W3023862215 cites W2165064295 @default.
• W3023862215 cites W2165902002 @default.
• W3023862215 cites W2341016265 @default.
• W3023862215 cites W2485201125 @default.
• W3023862215 cites W2548549197 @default.
• W3023862215 cites W2617060845 @default.
• W3023862215 cites W2752437404 @default.
• W3023862215 cites W2775528055 @default.
• W3023862215 doi "https://doi.org/10.1097/md.0000000000019989" @default.
• W3023862215 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7220364" @default.
• W3023862215 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32384452" @default.
• W3023862215 hasPublicationYear "2020" @default.
• W3023862215 type Work @default.
• W3023862215 sameAs 3023862215 @default.
• W3023862215 citedByCount "4" @default.
• W3023862215 countsByYear W30238622152022 @default.
• W3023862215 countsByYear W30238622152023 @default.
• W3023862215 crossrefType "journal-article" @default.
• W3023862215 hasAuthorship W3023862215A5027438574 @default.
• W3023862215 hasAuthorship W3023862215A5036897219 @default.
• W3023862215 hasAuthorship W3023862215A5066805252 @default.
• W3023862215 hasAuthorship W3023862215A5070127299 @default.
• W3023862215 hasAuthorship W3023862215A5070396701 @default.
• W3023862215 hasAuthorship W3023862215A5091021089 @default.
• W3023862215 hasBestOaLocation W30238622151 @default.
• W3023862215 hasConcept C126322002 @default.
• W3023862215 hasConcept C126838900 @default.
• W3023862215 hasConcept C142724271 @default.
• W3023862215 hasConcept C163716698 @default.
• W3023862215 hasConcept C2775945674 @default.
• W3023862215 hasConcept C2779053571 @default.
• W3023862215 hasConcept C2779902710 @default.
• W3023862215 hasConcept C2780441642 @default.
• W3023862215 hasConcept C2781156865 @default.
• W3023862215 hasConcept C2910851616 @default.
• W3023862215 hasConcept C2984398910 @default.
• W3023862215 hasConcept C2989005 @default.
• W3023862215 hasConcept C71924100 @default.
• W3023862215 hasConceptScore W3023862215C126322002 @default.
• W3023862215 hasConceptScore W3023862215C126838900 @default.
• W3023862215 hasConceptScore W3023862215C142724271 @default.
• W3023862215 hasConceptScore W3023862215C163716698 @default.
• W3023862215 hasConceptScore W3023862215C2775945674 @default.
• W3023862215 hasConceptScore W3023862215C2779053571 @default.
• W3023862215 hasConceptScore W3023862215C2779902710 @default.
• W3023862215 hasConceptScore W3023862215C2780441642 @default.
• W3023862215 hasConceptScore W3023862215C2781156865 @default.
• W3023862215 hasConceptScore W3023862215C2910851616 @default.
• W3023862215 hasConceptScore W3023862215C2984398910 @default.
• W3023862215 hasConceptScore W3023862215C2989005 @default.
• W3023862215 hasConceptScore W3023862215C71924100 @default.
• W3023862215 hasIssue "19" @default.
• W3023862215 hasLocation W30238622151 @default.
• W3023862215 hasLocation W30238622152 @default.
• W3023862215 hasLocation W30238622153 @default.
• W3023862215 hasLocation W30238622154 @default.
• W3023862215 hasLocation W30238622155 @default.
• W3023862215 hasOpenAccess W3023862215 @default.
• W3023862215 hasPrimaryLocation W30238622151 @default.
• W3023862215 hasRelatedWork W1506663650 @default.
• W3023862215 hasRelatedWork W1976699642 @default.
• W3023862215 hasRelatedWork W1980815074 @default.
• W3023862215 hasRelatedWork W2016947595 @default.
• W3023862215 hasRelatedWork W2040399709 @default.
• W3023862215 hasRelatedWork W2405321811 @default.
• W3023862215 hasRelatedWork W2416481685 @default.
• W3023862215 hasRelatedWork W3023862215 @default.
• W3023862215 hasRelatedWork W3028882174 @default.

• next